Richard Schumacher

Richard Schumacher

Algemeen Directeur bij PRESSURE BIOSCIENCES, INC.

Vermogen: 13 227 $ op 30-04-2024

73 jaar
Commercial Services
Health Technology
Consumer Services

Oorsprong van het eerstegraads netwerk van Richard Schumacher

EntiteitType entiteitIndustrie
Public Company Medical Specialties 31
1
Subsidiary Miscellaneous Commercial Services 1

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Richard Schumacher via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Industrial Machinery

Edmund Ting

Chief Tech/Sci/R&D Officer

GE AEROSPACE Industrial Machinery

Jeffrey Peterson

Corporate Officer/Principal

ALSERES PHARMACEUTICALS, INC. Medical Specialties

Susan M. Flint

Richard M. Thorn

Chief Tech/Sci/R&D Officer

Chief Operating Officer

AFFILIATED MANAGERS GROUP, INC. Investment Managers

Daniel Joseph Shea

Comptroller/Controller/Auditor

Miscellaneous Commercial Services

Edward Myles

Joseph Luis Damasio

Corporate Officer/Principal

Comptroller/Controller/Auditor

College/University

Kevin W. Quinlan

Susan M. Flint

Edmund Ting

Graduate Degree

Graduate Degree

Undergraduate Degree

University of Pennsylvania College/University

P. Thomas Vogel

Richard M. Thorn

Masters Business Admin

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Edmund Ting

Jeffrey Peterson

Doctorate Degree

Graduate Degree

Boston College College/University

Daniel Joseph Shea

Joseph Luis Damasio

Undergraduate Degree

Masters Business Admin

Miscellaneous Commercial Services

Jeffrey Peterson

Founder

The Coalition for 21st Century Medicine

Jeffrey Peterson

Founder

Baybio Institute

Jeffrey Peterson

Director/Board Member

Sharpe, Peterson, Ocheltree & Associates, Inc.

Jeffrey Peterson

Chief Executive Officer

The American International School of Conakry College/University

Jeffrey Peterson

Director/Board Member

Personalized Medicine LLC

Jeffrey Peterson

Corporate Officer/Principal

Abbott Laboratories South Africa (Pty) Ltd.

Jeffrey Peterson

Chief Executive Officer

Stanford University College/University

John B. Hollister

Undergraduate Degree

SKYE BIOSCIENCE, INC. Pharmaceuticals: Major

John B. Hollister

Chief Executive Officer

Claremont Graduate University College/University

John B. Hollister

Masters Business Admin

NORTHSIGHT CAPITAL, INC. Internet Software/Services

John B. Hollister

Chief Executive Officer

GRAPEFRUIT USA, INC. Pharmaceuticals: Other

John B. Hollister

Director/Board Member

Miscellaneous Commercial Services

John B. Hollister

Founder

Veritomyx, Inc.

Jeffrey Peterson

Chief Executive Officer

Miscellaneous Commercial Services

Jeffrey Peterson

Chief Executive Officer

PANACOS PHARMACEUTICALS, INC. Biotechnology

Graham P. Allaway

Founder

EASTERLY ACQUISITION CORP Financial Conglomerates

Daniel Joseph Shea

Director of Finance/CFO

ICAD, INC. Medical Specialties

Daniel Joseph Shea

Director of Finance/CFO

Miscellaneous Manufacturing

Edmund Ting

Chief Tech/Sci/R&D Officer

Home Furnishings

Edmund Ting

Corporate Officer/Principal

Miscellaneous Commercial Services

Michael Urdea

Chairman

Washington State University College/University

Michael Urdea

Doctorate Degree

ADAMAS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Michael Urdea

Director/Board Member

Semiconductors

Michael Urdea

Director/Board Member

Medical/Nursing Services

Michael Urdea

Founder

The University of California, San Francisco College/University

Michael Urdea

Corporate Officer/Principal

Northern Arizona University College/University

Michael Urdea

Undergraduate Degree

Nucleic Acid Diagnostics, Inc.

Michael Urdea

Founder

Statistieken

Internationaal

Verenigde Staten 43
Ierland 2
Zuid-Afrika 2

Sectoraal

Health Technology 12
Consumer Services 10
Commercial Services 7
Producer Manufacturing 4
Finance 4

Operationeel

Director/Board Member 58
Corporate Officer/Principal 54
Director of Finance/CFO 33
President 29
Chief Executive Officer 26
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU